Membership Home Portfolio Stocks Options Funds ETFs CEFsnew Markets Tools Real Life Finance Discuss
Home>Topics>>UPDATE 1-Santarus, Depomed settle dispute with Lupin

UPDATE 1-Santarus, Depomed settle dispute with Lupin

Reuters: Regulatory News

Wed, 22 Feb 2012

Feb 22 (Reuters) - Santarus Inc and Depomed Inc said they settled a patent dispute with generic drugmaker Lupin Ltd that will allow the Indian company to launch copycat version of their diabetes drug...

Read the rest of this article on Reuters: Regulatory News

Related Topics:

  1. India
Content Partners
Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
International Sites: Australia Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2010 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time. Russell 2000 quote is 10 minutes delayed.